Commentary
VOLUME: 36 | ISSUE: 2S | Jun 24, 2020 | PAGE: (84 - 86) | DOI: 10.24911/BioMedica//BioMedica/5-390
Lung & Gynecological Cancers: Has COVID-19 Impacted Patients?
Authors: Muhammad Talha Waheed , Mir Ibrahim Sajid , Samira Shabbir Balouch , Adnan Jabbar
Article Info
Authors
Muhammad Talha Waheed
Medical College, Aga Khan University, Karachi–Pakistan.
Mir Ibrahim Sajid
Medical College, Aga Khan University, Karachi–Pakistan.
Samira Shabbir Balouch
Section of Maxillofacial Trauma Surgery, Department of Surgery King Edward Medical University, Lahore–Pakistan.
Adnan Jabbar
Department of Adult Oncology, Section of Medicine Aga Khan University Hospital, Karachi–Pakistan.
Publication History
Received: May 21, 2020
Revised: May 26, 2020
Accepted: June 19, 2020
Published: June 24, 2020
Abstract
Coronavirus disease- 2019 (COVID-19) presented as case of viral pneumonia of unknown etiology is diagnosed by Reverse Transcriptase Polymerase Chain Reaction (RT-PCR) test of the samples from upper and lower respiratory tract. It can present as a mild flu-like illness for healthy adults yet it may become a life-threatening disease for the immunocompromised, such as cancer patients, by predisposing them to respiratory pathogens which may manifest as life-endangering pneumonia. Physicians should carefully evaluate their patient’s disease process and tailor treatment for individual patients to ensure that before doing beneficence, no further harm is done. Whether this is a wrinkle in time or the new normal, time will tell, but in light of recent evidence, ‘extra’ caution is the way forward.
Keywords: COVID-19, Lung Cancers, Gynaecological Cancers.
Pubmed Style
Muhammad Talha Waheed, Mir Ibrahim Sajid, Samira Shabbir Balouch, Adnan Jabbar. Lung & Gynecological Cancers: Has COVID-19 Impacted Patients?. BioMedica. 2020; 24 (June 2020): 84-86. doi:10.24911/BioMedica//BioMedica/5-390
Web Style
Muhammad Talha Waheed, Mir Ibrahim Sajid, Samira Shabbir Balouch, Adnan Jabbar. Lung & Gynecological Cancers: Has COVID-19 Impacted Patients?. https://biomedicapk.com/articles/online_first/390 [Access: April 29, 2024]. doi:10.24911/BioMedica//BioMedica/5-390
AMA (American Medical Association) Style
Muhammad Talha Waheed, Mir Ibrahim Sajid, Samira Shabbir Balouch, Adnan Jabbar. Lung & Gynecological Cancers: Has COVID-19 Impacted Patients?. BioMedica. 2020; 24 (June 2020): 84-86. doi:10.24911/BioMedica//BioMedica/5-390
Vancouver/ICMJE Style
Muhammad Talha Waheed, Mir Ibrahim Sajid, Samira Shabbir Balouch, Adnan Jabbar. Lung & Gynecological Cancers: Has COVID-19 Impacted Patients?. BioMedica. (2020), [cited April 29, 2024]; 24 (June 2020): 84-86. doi:10.24911/BioMedica//BioMedica/5-390
Harvard Style
Muhammad Talha Waheed, Mir Ibrahim Sajid, Samira Shabbir Balouch, Adnan Jabbar (2020) Lung & Gynecological Cancers: Has COVID-19 Impacted Patients?. BioMedica, 24 (June 2020): 84-86. doi:10.24911/BioMedica//BioMedica/5-390
Chicago Style
Muhammad Talha Waheed, Mir Ibrahim Sajid, Samira Shabbir Balouch, Adnan Jabbar. "Lung & Gynecological Cancers: Has COVID-19 Impacted Patients?." 24 (2020), 84-86. doi:10.24911/BioMedica//BioMedica/5-390
MLA (The Modern Language Association) Style
Muhammad Talha Waheed, Mir Ibrahim Sajid, Samira Shabbir Balouch, Adnan Jabbar. "Lung & Gynecological Cancers: Has COVID-19 Impacted Patients?." 24.June 2020 (2020), 84-86. Print. doi:10.24911/BioMedica//BioMedica/5-390
APA (American Psychological Association) Style
Muhammad Talha Waheed, Mir Ibrahim Sajid, Samira Shabbir Balouch, Adnan Jabbar (2020) Lung & Gynecological Cancers: Has COVID-19 Impacted Patients?. , 24 (June 2020), 84-86. doi:10.24911/BioMedica//BioMedica/5-390